Overview

A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer

Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
Comparing Docetaxel Plus Fulvestrant With Docetaxel in Patients With Metastatic Breast Cancer
Phase:
Phase 2
Details
Lead Sponsor:
Fudan University
Treatments:
Docetaxel
Estradiol
Fulvestrant